Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer

[1] Kato H(2007)Surgical treatment for esophageal cancer. Current issues Digest Surg. 24 88-95

[2] Fukuchi M(2003)Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma Ann Thor Cardiovasc Surg. 9 6-13

[3] Miyazaki T(1994)Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary Semin Oncol. 21 474-482

[4] Kuwano H(1992)Prolonged chemotherapy for localised squamous carcinoma of the oesophagus Eur J Cancer. 28A 880-884

[5] Nakajima M(1988)Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus Ann Thorac Surg. 45 357-363

[6] Miyazaki T(1992)Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial Jpn J Clin Oncol. 22 172-176

[7] Kato H(2001)Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407) Jpn J Clin Oncol. 31 419-423

[8] Ajani JA(2011)Phase II study of combined chemotherapy with docetaxel, CDDP and 5-FU for highly advanced esophageal cancer Anticancer Res. 31 633-638

[9] Ajani JA(2014) Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer Ann Surg Oncol. 21 2838-3844

[10] Ryan B(1989)Pharmacokinetics of (glycolate-0,0′)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin Cancer Chemother Pharmacol. 23 243-246

[1] Kato H(2007)Surgical treatment for esophageal cancer. Current issues Digest Surg. 24 88-95

[2] Fukuchi M(2003)Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma Ann Thor Cardiovasc Surg. 9 6-13

[3] Miyazaki T(1994)Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary Semin Oncol. 21 474-482

[4] Kuwano H(1992)Prolonged chemotherapy for localised squamous carcinoma of the oesophagus Eur J Cancer. 28A 880-884

[5] Nakajima M(1988)Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus Ann Thorac Surg. 45 357-363

[6] Miyazaki T(1992)Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial Jpn J Clin Oncol. 22 172-176

[7] Kato H(2001)Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407) Jpn J Clin Oncol. 31 419-423

[8] Ajani JA(2011)Phase II study of combined chemotherapy with docetaxel, CDDP and 5-FU for highly advanced esophageal cancer Anticancer Res. 31 633-638

[9] Ajani JA(2014) Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer Ann Surg Oncol. 21 2838-3844

[10] Ryan B(1989)Pharmacokinetics of (glycolate-0,0′)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin Cancer Chemother Pharmacol. 23 243-246